IL162780A0 - Method for producing modified peptide - Google Patents

Method for producing modified peptide

Info

Publication number
IL162780A0
IL162780A0 IL16278003A IL16278003A IL162780A0 IL 162780 A0 IL162780 A0 IL 162780A0 IL 16278003 A IL16278003 A IL 16278003A IL 16278003 A IL16278003 A IL 16278003A IL 162780 A0 IL162780 A0 IL 162780A0
Authority
IL
Israel
Prior art keywords
modified peptide
producing modified
producing
peptide
modified
Prior art date
Application number
IL16278003A
Other languages
English (en)
Original Assignee
Kenji Kangawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kenji Kangawa filed Critical Kenji Kangawa
Publication of IL162780A0 publication Critical patent/IL162780A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL16278003A 2002-04-11 2003-04-10 Method for producing modified peptide IL162780A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002109761 2002-04-11
PCT/JP2003/004590 WO2003084983A1 (fr) 2002-04-11 2003-04-10 Procede de production d'un peptide modifie

Publications (1)

Publication Number Publication Date
IL162780A0 true IL162780A0 (en) 2005-11-20

Family

ID=28786604

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16278003A IL162780A0 (en) 2002-04-11 2003-04-10 Method for producing modified peptide
IL162780A IL162780A (en) 2002-04-11 2004-06-29 A method for producing a protected peptide fragment

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL162780A IL162780A (en) 2002-04-11 2004-06-29 A method for producing a protected peptide fragment

Country Status (10)

Country Link
US (1) US7138489B2 (es)
EP (1) EP1493747B1 (es)
KR (1) KR101036524B1 (es)
CN (1) CN100491395C (es)
AU (1) AU2003236080B8 (es)
BR (1) BRPI0306644B8 (es)
CA (1) CA2472235C (es)
ES (1) ES2400703T3 (es)
IL (2) IL162780A0 (es)
WO (1) WO2003084983A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7357947B2 (en) * 2001-09-10 2008-04-15 Biomet, Inc. Bone graft material incorporating demineralized bone matrix and lipids
KR20050012224A (ko) * 2002-05-21 2005-01-31 다이이찌 산토리 파마 가부시키가이샤 그렐린 함유 의약 조성물
BR0314619A (pt) * 2002-09-18 2005-08-02 Univ Montreal Ct Hospitalier Chum Análogos de ghrh
CN102225966B (zh) 2004-10-19 2012-12-26 隆萨股份公司 用于固相肽合成的方法
US20070042501A1 (en) * 2005-08-20 2007-02-22 Institute Of Nuclear Energy Research A novel technology for the purity assay of TRODAT-1 raw material
US7763707B2 (en) * 2006-03-13 2010-07-27 Liat Mintz Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation
CN104853778A (zh) 2012-10-24 2015-08-19 第一三共株式会社 用于肌萎缩性侧索硬化的治疗剂
SG11201506885UA (en) 2013-03-21 2015-09-29 Sanofi Aventis Deutschland Synthesis of cyclic imide containing peptide products
EP2976331B1 (en) 2013-03-21 2017-03-01 Sanofi-Aventis Deutschland GmbH Synthesis of hydantoin containing peptide products
CN106459149A (zh) * 2014-03-04 2017-02-22 莫图斯治疗公司 H‑inp‑(d)bal‑(d)trp‑phe‑apc‑nh2及其可药用盐的液相合成的方法
EP3284851B1 (en) * 2015-04-14 2020-12-23 Hitgen Inc. Method for solid-phase synthesis of dna-encoded chemical library
EP3986919A1 (en) * 2019-06-18 2022-04-27 Fresenius Kabi iPSUM S.r.l. Process for the manufacture of glucagon

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118473A0 (en) 1995-06-02 1996-09-12 Suntory Ltd Staphylococcus aureus V8 protease genes coding therefor and a method for the production thereof
CA2198966C (en) 1996-03-04 2011-06-21 Yuji Suzuki Method for cleaving chimeric protein using processing enzyme
CA2198968C (en) 1996-03-04 2010-02-09 Toyofumi Masuda Process for production of secretory kex2 derivatives
AU765206B2 (en) 1998-01-30 2003-09-11 Daiichi Sankyo Company, Limited Process for producing peptide with the use of accessory peptide
US7344856B1 (en) 1999-03-04 2008-03-18 Asubio Pharma Co. Ltd. Method of controlling cleavage by OmpT protease
ES2154590B1 (es) 1999-05-20 2001-11-01 Lipotec Sa Procedimiento de sintesis de peptidos en fase solida
CA2380058C (en) * 1999-07-23 2011-08-09 Kenji Kangawa Novel peptides
DK1272507T3 (da) * 2000-04-12 2005-10-03 Amersham Health As Integrinbindende peptidderivater

Also Published As

Publication number Publication date
AU2003236080B8 (en) 2009-07-02
EP1493747A1 (en) 2005-01-05
BRPI0306644B8 (pt) 2021-05-25
CN100491395C (zh) 2009-05-27
CA2472235A1 (en) 2003-10-16
US7138489B2 (en) 2006-11-21
ES2400703T3 (es) 2013-04-11
US20050131208A1 (en) 2005-06-16
AU2003236080A1 (en) 2003-10-20
WO2003084983A1 (fr) 2003-10-16
KR101036524B1 (ko) 2011-05-24
KR20050012717A (ko) 2005-02-02
CA2472235C (en) 2012-05-22
EP1493747B1 (en) 2012-12-19
AU2003236080B2 (en) 2009-06-11
EP1493747A4 (en) 2007-11-28
CN1612891A (zh) 2005-05-04
BRPI0306644B1 (pt) 2018-02-14
IL162780A (en) 2013-10-31
BR0306644A (pt) 2005-04-26

Similar Documents

Publication Publication Date Title
PL376821A1 (pl) Sposoby zwiększania produkcji polipeptydów
EP1514928A4 (en) METHOD FOR CONSTRUCTING ANTIBODIES
GB0208104D0 (en) Method
GB0203306D0 (en) Method
GB0211975D0 (en) Method
AU2003283174A8 (en) Method for protein production
EP1437326A4 (en) PROCESS FOR THE PREPARATION OF Si
IL162780A0 (en) Method for producing modified peptide
AU2003294691A8 (en) Method for producing leather
AU2003258070A8 (en) Electrodionization method
GB0214209D0 (en) Method
GB0213261D0 (en) Method
GB0205509D0 (en) Method
IL164506A0 (en) Method for producing canthaxanthin
GB0209296D0 (en) Method
HK1082000A1 (en) Method for producing cephalexin
EP1698703A4 (en) PROCESS FOR DIPEPTIDE PRODUCTION
IL172332A0 (en) Method for producing a polypeptide
AU2003253813A8 (en) Method for colpoplasty
EP1546186A4 (en) PROCESS FOR SYNTHESIS OF PEPTIDES
AU2003286092A8 (en) Method for producing insulated elements
EP1556396A4 (en) METHOD OF PRODUCING 2-DESOXY-L-RIBOSE
PL372298A1 (en) Method for producing interferon
EP1658375A4 (en) PROCESS FOR THE PREPARATION OF DIPEPTIDES
GB0208383D0 (en) Method